Long-term results after treatment of basal cell carcinoma of the eyelid in Southwestern Finland

European Journal of Ophthalmology

Volumn 17, Issue 4, 2007, Pages 494-500

  Paavilainen, V ^a,b   Tuominen, J ^a   Aho, V V ^a   Saari, K Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Basal cell carcinoma; Eyelid; Follow up; Localization; Recurrence; Treatment

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; EYELID; EYELID CARCINOMA; FINLAND; FOLLOW UP; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; SKIN CANCER; TUMOR VOLUME;

EID: 35348939593     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700403     Document Type: Article

References (27)

1. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993; 38: 169-92.
2. Saari KM, Paavilainen V, Tuominen J, Collan Y. Epidemiology of basal cell carcinoma of the eyelid in southwestern Finland. Graefes Arch Clin Exp Ophthalmol 2001; 239: 230-3.
3. Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology 2001; 108: 2088-100.
4. Sigurdsson H, Agnarsson BA. Basal cell carcinoma of the eyelid. Risk of recurrence according to adequacy of surgical margins. Acta Ophthalmol Scand 1998; 76: 477-80.
5. Lindgren G, Lindblom B, Ternesten Bratel A, Mölne L, Larko O. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. I. Characteristics of the tumours and details of the procedure. Acta Ophthalmol Scand 2000; 78: 425-9.
6. Doxanas MT, Green WR, Iliff CE. Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol 1981; 91: 726-36.
7. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631-6.
8. Lindgren G, Lindblom B, Larko O. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. II. Reconstruction and follow-up. Acta Ophthalmol Scand 2000; 78: 430-6.
9. Smeets NWJ, Krekels GAM, Ostertag JU, et al. Surgical excision vs Mohs micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364: 1766-72.
10. Walker P, Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 2006; 47: 1-12.
11. Griffiths RW, Suvarna SK, Stone J. Do basal cell carcinomas recur after complete conventional surgical excision? Br J Plast Surg 2005; 58: 795-805.
12. Swetter SM, Boldrick JC, Pierre P, Wong P, Egbert BM. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinoma: rate of tumour regression in excisional specimens. J Cutan Pathol 2003; 30: 139-46.
13. Gupta M, Puri P, Kamal A, Nelson ME. Complete spontaneous regression of a basal cell carcinoma. Eye 2003; 17: 262-3.
14. Tuppurainen K. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graefes Arch Clin Exp Ophthalmol 1995; 233: 205-8.
15. Lindgren G, Larko O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997; 36: 742-6.
16. Buschmann W. A reappraisal of cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol 2002; 86: 453-7.
17. Payne JW, Duke JR, Butner R, Eifzig DE. Basal cell carcinomas of the eyelids: a long term follow up study. Arch Ophthalmol 1969; 81: 553-8.
18. Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 1999; 106: 746-50.
19. Allali J, D'Hermies F, Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica 2005; 219: 57-71.
20. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998; 147: 722-6.
21. Pukkala E. Cancer risk by social class and occupation: a survey of 109,000 cancer cases among Finns of working age. Contrib Epidemiol Biostat 1995; 7: 1-277.
22. Goldberg LH. Basal cell carcinoma. Lancet 1996; 347: 663-7.
23. Tang M, Htun H, Cheng Y, Dahlberg JE. Suppression of cyclobutane and mean value of 6-4 dipyhmidine formation in triple-stranded H-DNA. Biochemistry 1991; 30: 7021-6.
24. Kivistö K, Punnonen K, Toppari J, Leino L. Urocanic acid suppresses the activation of human neutrophils in vitro. Inflammation 1996; 20: 451-59.
25. Kammayer MR, Pavel S, Asghar SS, Bos JD, Teunissen MBM. Prolonged increase of cis-urocanic acid levels in human skin and urine after single total-body ultraviolet exposures. Photochem Photobiol 1997; 65: 593-8.
26. Oikarinen A, Raitio A. Melanoma and other skin cancers in circumpolar areas. Int J Circumpolar Health 2000; 59: 52-6.
27. Slaper H, Volders GJ, Daniel JS, de Gruijl FR, van der Leun JC. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 1996; 384: 256-8.